University of Connecticut
Storrs, Connecticut, 06269-1020, United States
Location status: Recruiting
NCT Number: NCT05283382
To examine the extent to which Cannabidiol (CBD) enhances fear conditioning extinction in college undergraduates who show elevated social anxiety. Undergraduates who display elevated social anxiety on standard assessments will be recruited at the University of Connecticut. All participants will be put in a standard fear conditioning paradigm where they are conditioned to fear a face that occasionally is followed by a shock to their wrist. The other face never is paired with a shock. After everybody learns this, half of the participants will receive 600 mg CBD Isolate Gel Capsules one time, and the other half will receive a placebo dose. Participants will then be presented with the faces with no shocks, and the rate and duration of extinction as measured by electrodermal response as well as subjective fear ratings via a visual analogue scale will be examined. It is hypothesized that participants that receive CBD will display enhanced extinction compared to the placebo group, as evidenced by reduced electrodermal response and reduced visual analogue fear ratings.
Interested in participating?
Request Info18 year–50 year
All sexes
Interventional
Early Phase 1
Storrs, Connecticut, 06269-1020, United States
Location status: Recruiting
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants will receive a one-time dose of 600 mg Cannabidiol Isolate Gel Capsules in the form of six 100mg capsules.
Participants will receive a one-time dose of placebo capsules in the form of six capsules.
Time frame: 20 minutes
Electrodermal response as measured by galvanic skin response electrodes that are attached to two of the fingers via sticker electrodes. These passively measure the conductance of the sweat glands on the fingers.
Contact information is provided by the study sponsor or research team.
University of Connecticut
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06436079
Anxiety Disorders, Anxiety and Fear
Palamós, Girona, Spain
View Trial DetailsNCT06697275
Acute Leukemia, Anxiety Disorders
Bordeaux, France
View Trial DetailsNCT06004115
Anxiety Disorders, Anxiety and Fear
Tulsa, Oklahoma, United States
View Trial DetailsNCT06531980
Adolescent - Emotional Problem, Anxiety
Bergen, Vestland, Norway
View Trial Details